5-Methylmethiopropamine

5-Methylmethiopropamine (5-MMPA, mephedrene) is a stimulant drug which is a ring-substituted derivative of methiopropamine. It is not a substituted cathinone derivative like mephedrone, as it lacks a ketone group at the β position of the aliphatic side chain, but instead more closely resembles substituted amphetamines. It has been sold as a designer drug, first being identified in Germany in June 2020.[1][2][3]

5-Methylmethiopropamine
Legal status
Legal status
Identifiers
IUPAC name
  • N-methyl-1-(5-methylthiophen-2-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC9H15NS
Molar mass169.29 g·mol−1
3D model (JSmol)
SMILES
  • CC1=CC=C(S1)CC(C)NC
InChI
  • InChI=1S/C9H15NS/c1-7(10-3)6-9-5-4-8(2)11-9/h4-5,7,10H,6H2,1-3H3
  • Key:HZICDJQMPRFRKC-UHFFFAOYSA-N

See also

References
  1. "EU Early Warning System Situation Report. Situation report 2". European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 10 August 2020. {{cite web}}: Missing or empty |url= (help)
  2. "Info" (PDF). www.aekwien.at. Retrieved 2021-05-13.
  3. New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. European Monitoring Center for Drugs and Drug Addiction, December 2020
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.